Vertex Pharmaceuticals Inc - Price Analysis Snapshot

This Report features up to a ten-year record of the equity Price history for Vertex Pharmaceuticals Inc. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.

Vertex Pharmaceuticals Inc. The Group's principal activity is to discover, develop and market small molecule drugs for the treatment of serious diseases. These drugs used for the treatment of diseases like HIV infection, chronic hepatitis C virus infection, inflammatory and autoimmune disorders, cancer, bacterial infection, pain and other neurological diseases, independently and with collaborators. The Group's telaprevir drug candidate, is an oral hepatitis C protease inhibitor and new class of antiviral treatments in clinical development that target hepatitis C virus or HCV, infection, a life-threatening disease.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report